Joshua A Kazam - Net Worth and Insider Trading

Joshua A Kazam Net Worth

The estimated net worth of Joshua A Kazam is at least $712,113 dollars as of 2024-06-10. Joshua A Kazam is the Director of Allogene Therapeutics Inc and owns about 258,885 shares of Allogene Therapeutics Inc (ALLO) stock worth over $600,613. Joshua A Kazam is also the Director of Target Hospitality Corp and owns about 10,000 shares of Target Hospitality Corp (TH) stock worth over $111,500. Details can be seen in Joshua A Kazam's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joshua A Kazam has not made any transactions after 2022-01-12 and currently still holds the listed stock(s).

Transaction Summary of Joshua A Kazam

To

Joshua A Kazam Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joshua A Kazam owns 17 companies in total, including Kronos Bio Inc (KRON) , Allogene Therapeutics Inc (ALLO) , and Flying Eagle Acquisition Corp (FEAC.U) among others .

Click here to see the complete history of Joshua A Kazam’s form 4 insider trades.

Insider Ownership Summary of Joshua A Kazam

Ticker Comapny Transaction Date Type of Owner
KRON Kronos Bio Inc 2020-10-08 director
ALLO Allogene Therapeutics Inc 2022-01-12 director
FEAC.U Flying Eagle Acquisition Corp 2020-03-05 director
LIMIT LIMIT 2019-12-31 director
LIMIT LIMIT 2019-03-05 director
LIMIT LIMIT 2009-07-07 director
LIMIT LIMIT 2017-09-28 director
LIMIT LIMIT 2008-06-03 director
LIMIT LIMIT 2004-01-28 director
LIMIT LIMIT 2019-03-05 director
LIMIT LIMIT 2020-03-05 director
LIMIT LIMIT 2020-11-09 director
LIMIT LIMIT 2021-02-23 director
LIMIT LIMIT 2021-02-11 director
LIMIT LIMIT 2022-01-05 director
LIMIT LIMIT 2021-02-11 director
LIMIT LIMIT 2020-11-09 director

Joshua A Kazam Latest Holdings Summary

Joshua A Kazam currently owns a total of 2 stocks. Among these stocks, Joshua A Kazam owns 258,885 shares of Allogene Therapeutics Inc (ALLO) as of January 12, 2022, with a value of $600,613 and a weighting of 84.34%. Joshua A Kazam also owns 10,000 shares of Target Hospitality Corp (TH) as of March 5, 2019, with a value of $111,500 and a weighting of 15.66%.

Latest Holdings of Joshua A Kazam

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALLO Allogene Therapeutics Inc 2022-01-12 258,885 2.32 600,613
TH Target Hospitality Corp 2019-03-05 10,000 11.15 111,500

Holding Weightings of Joshua A Kazam


Joshua A Kazam Form 4 Trading Tracker

According to the SEC Form 4 filings, Joshua A Kazam has made a total of 1 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Allogene Therapeutics Inc is the acquisition of 15,000 shares on January 12, 2022, which cost Joshua A Kazam around $189,000.

According to the SEC Form 4 filings, Joshua A Kazam has made a total of 0 transactions in Target Hospitality Corp (TH) over the past 5 years. The most-recent trade in Target Hospitality Corp is the acquisition of 5,000 shares on March 5, 2019, which cost Joshua A Kazam around $51,000.

Insider Trading History of Joshua A Kazam

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joshua A Kazam Trading Performance

GuruFocus tracks the stock performance after each of Joshua A Kazam's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua A Kazam is -11.17%. GuruFocus also compares Joshua A Kazam's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua A Kazam within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joshua A Kazam's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joshua A Kazam

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -8.28 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -8.09 LIMIT LIMIT LIMIT LIMIT LIMIT

Joshua A Kazam Ownership Network

Ownership Network List of Joshua A Kazam

No Data

Ownership Network Relation of Joshua A Kazam

Insider Network Chart

Joshua A Kazam Owned Company Details

What does Kronos Bio Inc do?

Who are the key executives at Kronos Bio Inc?

Joshua A Kazam is the director of Kronos Bio Inc. Other key executives at Kronos Bio Inc include COO & General Counsel Barbara Kosacz , Chief Scientific Officer Christopher Dinsmore , and Chief Medical Officer & VP Jorge Dimartino .

Kronos Bio Inc (KRON) Insider Trades Summary

Over the past 18 months, Joshua A Kazam made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net sale of 69,004 shares made by Jorge Dimartino , a net sale of 39,461 shares made by Christopher Dinsmore , and a net sale of 18,643 shares made by Yasir B. Al-wakeel .

In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 169,293 shares of Kronos Bio Inc (KRON) were sold and 1,731,056 shares were bought by its insiders, resulting in a net purchase of 1,561,763 shares.

Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kronos Bio Inc Insider Transactions

No Available Data

Joshua A Kazam Mailing Address

Above is the net worth, insider trading, and ownership report for Joshua A Kazam. You might contact Joshua A Kazam via mailing address: 689 5th Avenue, 12th Floor, New York Ny 10022.

Discussions on Joshua A Kazam

No discussions yet.